Medicine and Dentistry
Patient
100%
Diffuse Large B-Cell Lymphoma
51%
Therapeutic Procedure
43%
Inpatient
28%
Lymphoma
21%
Multiple Myeloma
17%
Cohort Analysis
16%
Diagnosis
13%
Overall Survival
12%
Rituximab
11%
Diseases
11%
Prognosis
11%
Gene
11%
Acute Myeloid Leukemia
11%
Malignant Neoplasm
10%
B Cell
10%
Analysis
10%
Survival
9%
Follow up
9%
Myeloma
8%
Neoplasm
8%
Age
8%
Venous Thromboembolism
7%
Spontaneous Remission
7%
Combination Therapy
7%
Cells
7%
Hodgkin's Lymphoma
7%
PET-CT
7%
Progression Free Survival
6%
Assessment
6%
Cyclophosphamide Plus Doxorubicin Plus Prednisolone Plus Rituximab Plus Vincristine
6%
International Prognostic Index
6%
Hazard Ratio
5%
Biological Marker
5%
Hospital
5%
Non-Hodgkin Lymphoma
5%
Autologous Stem Cell Transplantation
5%
Evaluation Study
5%
B-Cell Chronic Lymphocytic Leukemia
5%
Drug Megadose
5%
Hematological Cancer
5%
Follicular Lymphoma
5%
Chemotherapy
5%
Biochemistry, Genetics and Molecular Biology
B Cell
8%
MicroRNA
7%
Nested Gene
5%
Protein
5%
Rituximab
5%